Corsmed, a Swedish startup founded in 2016 by Christos Xanthis and Anthony Aletras, offers an advanced MRI simulation platform that faithfully replicates the interfaces and results of real scanners. Based on research conducted at Lund University, Corsmed’s technology enables students, physicians, and technicians to safely train on realistic simulations without the need for physical equipment.
Accessible online, Corsmed’s simulator generates MRI images using the real physics of magnetic resonance imaging. It includes a wide range of sequences, parameters, and anatomical options, covering all parts of the body and numerous pathologies. The tool also provides post-processing capabilities, 3D visualization, and a DICOM image analyzer, meeting the needs of professionals seeking to refine their skills or teach advanced practices.
Corsmed currently employs 24 people across Stockholm, Lund, and Thessaloniki. Its solution is already used in oncology hospitals in the UK and the US to train medical teams.
The startup recently raised $3.5 million (€3.2 million) in a seed funding round led by Luminar Ventures and Big Pi Ventures. Previously, Corsmed secured SEK 26.4 million (€3 million) in 2021 from investors including Andreas Ehn, Gerhard Dahl, and Göran Nordlund through Fore C. This funding aims to accelerate the commercialization of its technology and expand its impact in the healthcare sector.
